Balancing thromboembolic risk against vitamin K antagonist-related bleeding and accelerated calcification: is fondaparinux the Holy Grail for end-stage renal disease patients with atrial fibrillation?

被引：3
|
作者：
Fiaccadori, Enrico [1 ]
Maggiore, Umberto [2 ]
Regolisti, Giuseppe [1 ]
机构：
[1] Univ Parma, Sch Med, Dept Clin & Expt Med, Acute & Chron Renal Failure Unit, I-43100 Parma, Italy
[2] Univ Parma, Sch Med, Kidney & Pancreas Transplant Unit, I-43100 Parma, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2013年 / 28卷 / 12期
关键词：
CHRONIC KIDNEY-DISEASE; TERM HEMODIALYSIS-PATIENTS; VASCULAR CALCIFICATION; DIALYSIS PATIENTS; ANTICOAGULATION; THERAPY; MORTALITY; SURVIVAL; UPDATE; STROKE;
D O I：
10.1093/ndt/gft334
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：2923 / 2928
页数：6
相关论文
共 18 条
  • [1] Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease
    Nishimura, Marin
    Hsu, Jonathan C.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (01): : 131 - 140
  • [2] Oral anticoagulants in patients with atrial fibrillation and end-stage renal disease: Walking the tightrope between thromboembolic and bleeding risk
    Vitolo, Marco
    Gerra, Luigi
    Boriani, Giuseppe
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 119 : 39 - 41
  • [3] Apixaban Vs Vitamin K Antagonist As Anticoagulant Therapy in Patients with End-Stage Kidney Disease on Hemodialysis and with Atrial Fibrillation
    Muzio, Sofia
    Artaza, Gonzalo
    Benitez Hidalgo, Olga
    Cortina, Vicente
    Campoy, Desiree
    Beas, Francisco
    Bosch, Marc
    Serra, Marina
    Bosch, Francesc
    Olivera, Pavel E.
    [J]. BLOOD, 2023, 142
  • [4] Stroke and Bleeding in Patients with Atrial Fibrillation and End-Stage Renal Disease Treated with Apixaban Versus Warfarin
    Lara, Joao Manoel Da Silveira
    Dourado, Claudia
    [J]. BLOOD, 2023, 142
  • [5] USE OF WARFARIN IN END-STAGE RENAL DISEASE AND ATRIAL FIBRILLATION: RISK OF STROKE AND BLEEDING - A NATIONWIDE COHORT STUDY
    Carlson, Nicholas
    Gislason, Gunnar
    Torp-Pedersen, Christian
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 3 - 3
  • [6] Does Atrial Fibrillation Increase the Risk of Developing End-stage Renal Disease in Patients with Chronic Kidney Disease?
    Suwanwongse, Kulachanya
    Shabarek, Nehad
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (02)
  • [7] Does the risk exceed the benefit for anticoagulation in end-stage renal disease patients with nonrheumatic atrial fibrillation?
    Yalamanchili, Venkata
    Reilly, Robert F.
    [J]. SEMINARS IN DIALYSIS, 2011, 24 (04) : 387 - 388
  • [8] Statin therapy lowers the risk of new-onset atrial fibrillation in patients with end-stage renal disease
    Ho, Li-Ting
    Lin, Lian-Yu
    Yang, Yao-Hsu
    Wu, Cho-Kai
    Juang, Jyh-Ming Jimmy
    Wang, Yi-Chih
    Tsai, Chia-Ti
    Lai, Ling-Ping
    Hwang, Juey-Jen
    Chiang, Fu-Tien
    Lin, Jiunn-Lee
    Chen, Pau-Chung
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 201 : 538 - 543
  • [9] Risk profiles for acute health events after incident atrial fibrillation in patients With end-stage renal disease on hemodialysis
    Airy, Medha
    Chang, Tara, I
    Ding, Victoria Y.
    Goldstein, Benjamin A.
    Bansal, Nisha
    Niu, Jingbo
    Navaneethan, Sankar D.
    Turakhia, Mintu P.
    Winkelmayer, Wolfgang C.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (09) : 1590 - 1597
  • [10] Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis: A nationwide, population-based study in Taiwan
    Shen, Cheng-Huang
    Zheng, Cai-Mei
    Kiu, Kee-Thai
    Chen, Hsin-An
    Wu, Chia-Chang
    Lu, Kuo-Cheng
    Hsu, Yung-Ho
    Lin, Yuh-Feng
    Wang, Yuan-Hung
    [J]. MEDICINE, 2016, 95 (25)
12